Suzhou Pharma Services has received the latest 2010 cGMP certification from the Chinese SFDA for its development and manufacturing facility in Suzhou, China. The facility is also U.S. FDA approved and inspected for solid oral dose manufacturing. The company recently upgraded the facility to include capabilities to support development of oral solid dose products with expertise in extended, sustained and modified release tablets and capsules.
“Suzhou Pharma is well positioned to offer our formulation and manufacturing services backed by our western experienced management team to companies in China and the Asia Pacific region looking for outsourcing partners operating under the latest GMP and quality standards,” said Marc Finn, director of business development. “It allows us to better support our local client’s growing needs in outsourced drug development, clinical trial material and formulation services for the Chinese and Global markets.”